Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Scheduling (national classification system) (24)
- (-) In Vitro Diagnostic medical devices (IVDs) (11)
- Advertising (248)
- Medicine safety (161)
- COVID-19 (144)
- Prescription medicines (142)
- Regulatory compliance (128)
- COVID-19 vaccines (88)
- Legislation (82)
- Therapeutic goods regulation (75)
- Listed medicines (54)
- Non-prescription medicines (50)
- Safety (48)
- Medical devices safety (43)
- Vaping hub (39)
- Manufacturing (34)
- Complementary medicines (33)
- Labelling and packaging (29)
- Assessed listed medicines (26)
- Over the counter (OTC) medicines (26)
- Australian Register of Therapeutic Goods (ARTG) (22)
- Compliance and enforcement hub (22)
- Medicinal cannabis hub (21)
- Import and export (19)
- Alert/Advisory (18)
- Shortages (12)
- Sunscreens (8)
- Weight loss products (8)
- Advisory bodies and committees (5)
- Clinical trials (3)
- Cosmetics (3)
- Blood and blood components (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Biological medicines (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Filters applied:Clear all
Search
35 result(s) found, displaying 26 to 35
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations
-
Media releasesPending the final outcome of the process required by law, it has been decided to defer the proposed restriction on importation of personal nicotine vaporisers and, separately, nicotine for use in e-cigarettes
-
Media releasesToday the TGA announced an interim decision that, if made final, would clarify the regulation of e-cigarettes containing nicotine, and nicotine fluids for vaping
-
NewsChanges will be made to the regulation of nappy rash products on 1 January 2020
-
News
-
Media releasesThere will not be a decision announced on scheduling of alkyl nitrites on 29 November 2018. Further public consultation will be undertaken.
-
NewsList of OTC codeine-containing products moving to prescription only
-
NewsThe codeine re-scheduling RIS and associated economic modelling report are now available
-
Media releasesThe Therapeutic Goods Administration has published an interim decision on a proposal to up-schedule codeine
-
NoticesTherapeutic Goods Order No. 1 of 2010.